Literature DB >> 25418487

Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.

D M Foureau1, T L Walling, V Maddukuri, W Anderson, K Culbreath, D E Kleiner, W A Ahrens, C Jacobs, P B Watkins, R J Fontana, N Chalasani, J Talwalkar, W M Lee, A Stolz, J Serrano, H L Bonkovsky.   

Abstract

Drug-induced liver injury (DILI) is often caused by innate and adaptive host immune responses. Characterization of inflammatory infiltrates in the liver may improve understanding of the underlying pathogenesis of DILI. This study aimed to enumerate and characterize leucocytes infiltrating liver tissue from subjects with acute DILI (n = 32) versus non-DILI causes of acute liver injury (n = 25). Immunostains for CD11b/CD4 (Kupffer and T helper cells), CD3/CD20 (T and B cells) and CD8/CD56 [T cytotoxic and natural killer (NK) cells] were evaluated in biopsies from subjects with acute DILI, either immunoallergic (IAD) or autoimmune (AID) and idiopathic autoimmune (AIH) and viral hepatitis (VH) and correlated with clinical and pathological features. All biopsies showed numerous CD8(+) T cells and macrophages. DILI cases had significantly fewer B lymphocytes than AIH and VH and significantly fewer NK cells than VH. Prominent plasma cells were unusual in IAD (three of 10 cases), but were associated strongly with AIH (eight of nine) and also observed in most with AID (six of nine). They were also found in five of 10 cases with VH. Liver biopsies from subjects with DILI were characterized by low counts of mature B cells and NK cells in portal triads in contrast to VH. NK cells were found only in cases of VH, whereas AIH and VH both showed higher counts of B cells than DILI. Plasma cells were associated most strongly with AIH and less so with AID, but were uncommon in IAD.
© 2014 British Society for Immunology.

Entities:  

Keywords:  autoimmunity; drug-induced liver injury; inflammation; viral hepatitis

Mesh:

Substances:

Year:  2015        PMID: 25418487      PMCID: PMC4367092          DOI: 10.1111/cei.12558

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Mechanisms of hepatotoxicity.

Authors:  Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

Review 2.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

3.  Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.

Authors:  Don C Rockey; Leonard B Seeff; James Rochon; James Freston; Naga Chalasani; Maurizio Bonacini; Robert J Fontana; Paul H Hayashi
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

4.  Detecting plasma cell precursors in autoimmune hepatitis.

Authors:  Carlos A Rubio
Journal:  In Vivo       Date:  2012 Mar-Apr       Impact factor: 2.155

5.  Surveillance for acute viral hepatitis--United States, 2006.

Authors:  Annemarie Wasley; Scott Grytdal; Kathleen Gallagher
Journal:  MMWR Surveill Summ       Date:  2008-03-21

6.  Autoimmune liver disease: overlap and outliers.

Authors:  Mary K Washington
Journal:  Mod Pathol       Date:  2007-02       Impact factor: 7.842

7.  Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.

Authors:  A W Cheever; M E Williams; T A Wynn; F D Finkelman; R A Seder; T M Cox; S Hieny; P Caspar; A Sher
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

Review 8.  Drug-induced liver injury with autoimmune features.

Authors:  Andrew S deLemos; David M Foureau; Carl Jacobs; Will Ahrens; Mark W Russo; Herbert L Bonkovsky
Journal:  Semin Liver Dis       Date:  2014-05-31       Impact factor: 6.115

9.  Drug-induced liver injury.

Authors:  Neil Kaplowitz
Journal:  Clin Infect Dis       Date:  2004-03-01       Impact factor: 9.079

10.  Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.

Authors:  David E Kleiner; Naga P Chalasani; William M Lee; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Paul H Hayashi; Timothy J Davern; Victor Navarro; Rajender Reddy; Jayant A Talwalkar; Andrew Stolz; Jiezhun Gu; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2013-12-18       Impact factor: 17.425

View more
  24 in total

Review 1.  Hepatotoxicity Associated with the Use of Anti-TNF-α Agents.

Authors:  Joshua B French; Maurizio Bonacini; Marwan Ghabril; David Foureau; Herbert L Bonkovsky
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

Review 2.  Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Authors:  Barbara L F Kaplan; Jinze Li; John J LaPres; Stephen B Pruett; Peer W F Karmaus
Journal:  Toxicol Sci       Date:  2015-06       Impact factor: 4.849

Review 3.  Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.

Authors:  Robert J Fontana
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

Review 4.  Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.

Authors:  M Mosedale; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2017-01-11       Impact factor: 6.875

5.  Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response.

Authors:  Jessica Whritenour; Mira Ko; Qing Zong; Jianying Wang; Karrie Tartaro; Patricia Schneider; Ellen Olson; Maria Van Volkenburg; Jose Serrano; Paul Hayashi; Robert Fontana; Naga Chalasani; Herbert L Bonkovsky
Journal:  J Immunotoxicol       Date:  2017-12       Impact factor: 3.000

6.  Amoxicillin-Clavulanate-Induced Liver Injury.

Authors:  Andrew S deLemos; Marwan Ghabril; Don C Rockey; Jiezhun Gu; Huiman X Barnhart; Robert J Fontana; David E Kleiner; Herbert L Bonkovsky
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

7.  Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury.

Authors:  Luke Hillman; Michelle Gottfried; Maureen Whitsett; Jorge Rakela; Michael Schilsky; William M Lee; Daniel Ganger
Journal:  Am J Gastroenterol       Date:  2016-04-05       Impact factor: 10.864

8.  The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis.

Authors:  Guiqiang Wang; Atsushi Tanaka; Hong Zhao; Jidong Jia; Xiong Ma; Kenichi Harada; Fu-Sheng Wang; Lai Wei; Qixia Wang; Ying Sun; Yuan Hong; Huiying Rao; Cumali Efe; George Lau; Diana Payawal; Rino Gani; Keith Lindor; Wasim Jafri; Masao Omata; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-05-04       Impact factor: 6.047

Review 9.  Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.

Authors:  Aida Ortega-Alonso; Camilla Stephens; M Isabel Lucena; Raúl J Andrade
Journal:  Int J Mol Sci       Date:  2016-05-12       Impact factor: 5.923

Review 10.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.